1. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial. (4th July 2022) Authors: Møller-Bisgaard, S; Hørslev-Petersen, K; Ejbjerg, B; Hetland, ML; Christensen, R; Ørnbjerg, LM; Glinatsi, D; Møller, JM; Boesen, M; Stengaard-Pedersen, K; Madsen, OR; Jensen, B; Villadsen, JA; Hauge, EM; Bennett, P; Hendricks, O; Asmussen, K; Kowalski, M; Lindegaard, H; Bliddal, H Journal: Scandinavian journal of rheumatology Issue: Volume 51:Number 4(2022) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0366 Efficacy of Adalimumab in Patients with Axial Spondyloarthritis: Results of an Investigator-Initiated 12-Weeks Randomized Double-Blind Placebo Controlled Trial with a 12 Weeks Open-Label Extension Phase. (23rd January 2014) Authors: Pedersen, S. J.; Sørensen, IJ; Loft, AG; Hindrup, JS; Thamsborg, G; Asmussen, K; Kluger, E; Nørregaard, J; Christensen, TG; Jurik, AG; Møller, JM; Hasselquist, M; Skjødt, T; Mikkelsen, D; Østergaard, M Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗